Triple
T4200603
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | zanamivir |
E86054
|
entity |
| Predicate | discoveredBy |
P412
|
FINISHED |
| Object |
Mark von Itzstein
Mark von Itzstein is an Australian medicinal chemist and glycobiologist best known for leading the development of the anti-influenza drug zanamivir.
|
E422959
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69aed93b89f48190a31f6d57c760e42f |
elicitation | completed |
| NER | batch_69af0363bbb8819093f396afe91972e2 |
ner | completed |
| NED1 | batch_69b5962296b8819084b91de3f48b7658 |
ned_source_triple | completed |
| NED2 | batch_69b59e129d50819093836d446aa5a6d0 |
ned_description | completed |
| NEDg | batch_69b59a25a5bc8190a75c146bba994db1 |
nedg | completed |
Created at: March 9, 2026, 3:49 p.m.